arrow
J

Jae-Ho Yoon

The Catholic University of Korea
H指数:25
被引数:2,398

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic value of early lymphocyte dynamics during blinatumomab therapy in relapsed or refractory B-cell precursor acute lymphoblastic leukemia: A real-world retrospective study

在复发或难治性B细胞前体急性淋巴细胞白血病中,使用blinatumomab治疗期间早期淋巴细胞动态变化的预后价值:一项真实世界回顾性研究

2026-09-070
PRE
Predicting treatment-free remission after thrombopoietin receptor agonist therapy in immune thrombocytopenia: real-world outcomes from a Korean cohort

预测免疫性血小板减少症患者在促血小板生成素受体激动剂治疗后的无治疗缓解:来自韩国队列的真实世界结果

2026-03-010
PRE
Real-world treatment outcome and toxicity analysis of inotuzumab ozogamicin in adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia: multicenter prospective observational study

伊诺妥珠单抗(inotuzumab ozogamicin)在成人复发或难治性B细胞前体急性淋巴细胞白血病患者中的真实世界治疗效果与毒性分析:多中心前瞻性观察性研究

2025-12-160
OA
Ianalumab plus Eltrombopag in Immune Thrombocytopenia

Ianalumab plus Eltrombopag在免疫性血小板减少症中的应用

2025-12-010
PRE
BCR::ABL1-positive acute lymphoblastic leukemia as a high-risk feature of central nervous system relapse after allogeneic hematopoietic cell transplantation

BCR::ABL1阳性的急性淋巴细胞白血病是异基因造血细胞移植后中枢神经系统复发的危险因素。

2025-10-060
OA
Ponatinib Monotherapy in Adult Patients with Relapsed or Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia: A Real-World Retrospective Analysis Including Measurable Residual Disease Relapse

波纳替尼单药治疗成人复发性或难治性费城染色体阳性急性淋巴细胞白血病的真实世界回顾性分析:包括可测量微小残留病复发情况

2025-10-010
OAAI
Outcome of second allogeneic hematopoietic cell transplantation in adult patients with relapsed B-cell acute lymphoblastic leukemia in the era of new immunotherapeutic agents

成人复发B细胞急性淋巴细胞白血病患者在新免疫治疗药物时代的第二次异基因造血细胞移植结局

2025-06-170
PRE
Feasibility of a Total Body Irradiation-Augmented Reduced-Toxicity Conditioning Regimen with an Antithymocyte Globulin/Post-Transplantation Cyclophosphamide Combination for Haploidentical Donor Transplantation in Adult Acute Lymphoblastic Leukemia

异基因供者移植中成人急性淋巴细胞白血病采用抗胸腺细胞球蛋白/移植后环磷酰胺联合方案增敏的全身体外照射增强减毒预处理方案的安全性评估

2025-05-240
PRE
The Impact of Histologic Portal T-Cell Density on the Clinical Outcomes in Hepatic Graft-versus-Host Disease and Autoimmune Liver Diseases
2024-08-120
OA